Skip to content

Influence of Diagnosis and Treatment of Benign Paroxysmal Positional Vertigo (BPPV) in Geriatric Patients: A 10-Year Review (2015–2025)

Influence of Diagnosis and Treatment of Benign Paroxysmal Positional Vertigo (BPPV) in Geriatric Patients: A 10-Year Review (2015–2025)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039399
Enrollment
259
Registered
2026-06-11
Start date
2026-03-11
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign paroxysmal positional vertigo

Interventions

Group 1: Investigation of all patients treated for benign paroxysmal positional vertigo (BPPV) either inpatient or outpatient at Johanniter Clinics during the observation period from May 2015 to May 2

Sponsors

Johanniter Kliniken Bonn
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The data were obtained from inpatient and outpatient patients who were treated for benign paroxysmal positional vertigo between May 2015 and May 2025 at the Johanniter Kliniken Bonn, including the Johanniter Krankenhaus Bonn and the Waldkrankenhaus Bonn sites.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
The aim is to determine the frequency of benign paroxysmal positional vertigo (BPPV) in geriatric patients. Additionally, complications such as falls or fractures will be highlighted. An evaluation of the treatment of BPPV will also be conducted.

Countries

Germany

Contacts

Public ContactMichael Kowar

Johanniter Kliniken Bonn

michael.kowar@bn.johanniter-kliniken.de02285432207

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026